erythromycin has been researched along with Arrhythmia in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (14.29) | 18.7374 |
1990's | 9 (32.14) | 18.2507 |
2000's | 8 (28.57) | 29.6817 |
2010's | 7 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Fischer, C; Frommeyer, G; Kochhäuser, S; Lange, PS; Wasmer, K | 1 |
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M | 1 |
Gorelik, E; Masarwa, R; Matok, I; Muszkat, M; Perlman, A; Rotshild, V | 1 |
Nilsson, MF; Webster, WS | 1 |
Dixon, SN; Garg, AX; Hackam, DG; Jandoc, R; McArthur, E; Nash, DM; Trac, MH | 1 |
Li, C; Li, X; Liu, G; Wang, M; Wang, Z; Zhou, L | 1 |
Bannister, CA; Berni, E; Butler, CC; Currie, CJ; de Voogd, H; Halcox, JP; Jenkins-Jones, S; Jones, B; Ouwens, M | 1 |
Coker, SJ; Farkas, A | 1 |
Biertz, J; Breithardt, G; Bruns, HJ; Eckardt, L; Fabritz, L; Fleischer, D; Haverkamp, W; Kirchhof, P; Milberg, P; Ramtin, S; Reinsch, N | 1 |
Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A | 1 |
Crimin, K; Engtrakul, J; Fermini, B; Fossa, AA; O'Donnell, J; Wisialowski, T | 1 |
Carlson, W; Choo, PW; Faich, GA; Greineder, D; Hanrahan, JP; Platt, R | 1 |
Eiselt-Proteau, D; Haxby, D; Hedges, JR; Zechnich, AD | 1 |
Sabbah, A | 1 |
Kluger, MT | 1 |
Drici, MD; Knollmann, BC; Wang, WX; Woosley, RL | 1 |
De Clerck, F; Dujardin, K; Hondeghem, LM | 1 |
Cox, BF; Gintant, GA; Limberis, JT; McDermott, JS; Wegner, CD | 1 |
Cox, BF; Gintant, GA; McDermott, JS; Salmen, HJ | 1 |
Haefeli, WE; Ritz, R; Schoenenberger, RA; Weiss, P | 1 |
Gouyon, JB | 1 |
Bavoux, F; Beneton, C; Betremieux, T; Gouyon, JB; Petion, AM | 1 |
Lemery, R; Nattel, S; Ranger, S; Roy, D; Talajic, M | 1 |
Ragosta, M; Rosenfeld, LE; Weihl, AC | 1 |
Barret, B; Chaperon, A; Citron, B; Gras, H; Ponsonnaille, J; Richard, A; Trolese, JF | 1 |
Haberer, JP; Hummel, JC | 1 |
Anderson, KP; Freedman, RA; Green, LS; Mason, JW | 1 |
2 review(s) available for erythromycin and Arrhythmia
Article | Year |
---|---|
Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Erythromycin; Macrolides; Myocardial Infarction; Network Meta-Analysis; Risk Factors | 2018 |
Possible risk for cardiac arrhythmia related to intravenous erythromycin.
Topics: Aged; Arrhythmias, Cardiac; Electrocardiography; Erythromycin; Female; Hospitals, University; Humans; Infusions, Intravenous; Intensive Care Units; Linear Models; Male; Middle Aged; Monitoring, Physiologic; Pneumonia; Prospective Studies; Risk Factors; Switzerland; Time Factors | 1992 |
26 other study(ies) available for erythromycin and Arrhythmia
Article | Year |
---|---|
Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Domperidone; Drug Interactions; Erythromycin; Female; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Ondansetron; Proof of Concept Study; Rabbits; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antazoline; Anti-Bacterial Agents; Arrhythmias, Cardiac; Disease Models, Animal; Erythromycin; Histamine H1 Antagonists; Isolated Heart Preparation; Long QT Syndrome; Membrane Transport Modulators; Pinacidil; Rabbits; Refractory Period, Electrophysiological; Sotalol; Torsades de Pointes; Ventricular Fibrillation | 2018 |
Effects of macrolide antibiotics on rat embryonic heart function in vitro.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Bradycardia; Clarithromycin; Dose-Response Relationship, Drug; Embryo Culture Techniques; Erythromycin; Female; Heart; Macrolides; Male; Rats; Rats, Sprague-Dawley; Teratogens | 2014 |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Cohort Studies; Erythromycin; Female; Humans; Logistic Models; Macrolides; Male; Ontario; Propensity Score; Retrospective Studies; Risk Assessment; Risk Factors | 2016 |
Macrolides use and the risk of sudden cardiac death.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Coronary Artery Disease; Coronary Disease; Death, Sudden, Cardiac; Erythromycin; Humans; Macrolides; Plaque, Atherosclerotic; Risk Factors; Torsades de Pointes | 2016 |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; United Kingdom | 2017 |
Limited induction of torsade de pointes by terikalant and erythromycin in an in vivo model.
Topics: Action Potentials; Adrenergic alpha-1 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Blood Gas Analysis; Blood Pressure; Body Temperature; Chromans; Electrocardiography; Erythromycin; Heart Rate; Male; Piperidines; Quaternary Ammonium Compounds; Rabbits; Torsades de Pointes | 2002 |
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Clarithromycin; Electrocardiography; Erythromycin; Heart; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Rabbits; Time Factors; Torsades de Pointes | 2002 |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors | 2005 |
Combining erythromycin with other drugs may lead to sudden death.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Aryl Hydrocarbon Hydroxylases; Contraindications; Cytochrome P-450 CYP3A; Death, Sudden, Cardiac; Drug Interactions; Drug Therapy, Combination; Erythromycin; Humans; Oxidoreductases, N-Demethylating | 2005 |
Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Aza Compounds; Cell Line; Dose-Response Relationship, Drug; Erythromycin; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Guinea Pigs; Heart Rate; Humans; Ketolides; Moxifloxacin; Quinolines; Risk Factors; Torsades de Pointes | 2006 |
Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization.
Topics: Administration, Oral; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Boston; Cohort Studies; Death, Sudden, Cardiac; Drug Interactions; Electrocardiography; Erythromycin; Female; Health Maintenance Organizations; Heart Rate; Histamine H1 Antagonists; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Syncope; Terfenadine; Treatment Outcome; Ventricular Dysfunction | 1995 |
Possible interactions with terfenadine or astemizole.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Astemizole; Child; Drug Interactions; Drug Prescriptions; Erythromycin; Female; Humans; Ketoconazole; Male; Middle Aged; Retrospective Studies; Terfenadine | 1994 |
[Teldane update. Interview with Dr. Alfred Sabbah, chief of the immuno-allergology laboratory of the C.H.U. d'Angers. Interview by Dr. Pierre Ceddaha].
Topics: Adult; Arrhythmias, Cardiac; Child; Child, Preschool; Contraindications; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Erythromycin; Humans; Hypersensitivity; Inactivation, Metabolic; Incidence; Infant; Josamycin; Ketoconazole; Microsomes, Liver; Retrospective Studies; Risk; Terfenadine | 1993 |
Erythromycin--a pro-kinetic and pro-arrhythmogenic agent.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Erythromycin; Gastrointestinal Motility; Humans | 1997 |
Cardiac actions of erythromycin: influence of female sex.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Electrophysiology; Erythromycin; Female; Heart; Humans; In Vitro Techniques; Male; Rabbits; Risk Factors; Sex Factors | 1998 |
Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Electrocardiography; Electrophysiology; Erythromycin; Female; Organ Culture Techniques; Propanolamines; Rabbits | 2001 |
The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
Topics: Action Potentials; Animals; Anti-Infective Agents; Arrhythmias, Cardiac; Aza Compounds; Cisapride; Dogs; Erythromycin; Female; Fluoroquinolones; Imidazoles; In Vitro Techniques; Indoles; Long QT Syndrome; Male; Models, Biological; Moxifloxacin; Perfusion; Piperazines; Purkinje Fibers; Quinolines; Sotalol; Swine; Torsades de Pointes | 2001 |
Importance of species selection in arrythmogenic models of Q-T interval prolongation.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Electrocardiography; Erythromycin; In Vitro Techniques; Papillary Muscles; Rats; Species Specificity | 2002 |
The use of erythromycin lactobionate to facilitate the postpyloric passage of tubes in children.
Topics: Arrhythmias, Cardiac; Erythromycin; Humans; Infant, Newborn; Infusions, Intravenous; Intubation, Gastrointestinal; Pylorus | 1992 |
[Cardiotoxicity of intravenous erythromycin lactobionate in the neonatal period].
Topics: Arrhythmias, Cardiac; Erythromycin; Humans; Infant, Newborn; Infusions, Intravenous | 1991 |
Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism.
Topics: Action Potentials; Aged; Animals; Arrhythmias, Cardiac; Dogs; Electrocardiography; Erythromycin; Humans; In Vitro Techniques; Long QT Syndrome; Male; Purkinje Fibers; Quinidine; Tachycardia | 1990 |
Potentially fatal interaction between erythromycin and disopyramide.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Drug Interactions; Erythromycin; Female; Humans; Male; Tachycardia | 1989 |
[Electrophysiological study of pro-arrhythmogenic effects of erythromycin].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Electrocardiography; Erythromycin; Female; Heart Conduction System; Humans; Male; Middle Aged; Tachycardia | 1988 |
[Peroperative circulatory arrest after intravenous injection of erythromycin lactobionate].
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Erythromycin; Female; Humans; Injections, Intravenous; Tachycardia | 1988 |
Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome.
Topics: Adult; Arrhythmias, Cardiac; Cough; Erythromycin; Heart Ventricles; Humans; Long QT Syndrome; Male | 1987 |